Loading…

Convergent Signaling Pathways Controlled by LRP1 (Receptor-related Protein 1) Cytoplasmic and Extracellular Domains Limit Cellular Cholesterol Accumulation

The low density lipoprotein receptor-related protein 1 (LRP1) is a ubiquitously expressed cell surface receptor that protects from intracellular cholesterol accumulation. However, the underlying mechanisms are unknown. Here we show that the extracellular (α) chain of LRP1 mediates TGFβ-induced enhan...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of biological chemistry 2016-03, Vol.291 (10), p.5116-5127
Main Authors: El Asmar, Zeina, Terrand, Jérome, Jenty, Marion, Host, Lionel, Mlih, Mohamed, Zerr, Aurélie, Justiniano, Hélène, Matz, Rachel L., Boudier, Christian, Scholler, Estelle, Garnier, Jean-Marie, Bertaccini, Diego, Thiersé, Danièle, Schaeffer, Christine, Van Dorsselaer, Alain, Herz, Joachim, Bruban, Véronique, Boucher, Philippe
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The low density lipoprotein receptor-related protein 1 (LRP1) is a ubiquitously expressed cell surface receptor that protects from intracellular cholesterol accumulation. However, the underlying mechanisms are unknown. Here we show that the extracellular (α) chain of LRP1 mediates TGFβ-induced enhancement of Wnt5a, which limits intracellular cholesterol accumulation by inhibiting cholesterol biosynthesis and by promoting cholesterol export. Moreover, we demonstrate that the cytoplasmic (β) chain of LRP1 suffices to limit cholesterol accumulation in LRP1−/− cells. Through binding of Erk2 to the second of its carboxyl-terminal NPXY motifs, LRP1 β-chain positively regulates the expression of ATP binding cassette transporter A1 (ABCA1) and of neutral cholesterol ester hydrolase (NCEH1). These results highlight the unexpected functions of LRP1 and the canonical Wnt5a pathway and new therapeutic potential in cholesterol-associated disorders including cardiovascular diseases.
ISSN:0021-9258
1083-351X
DOI:10.1074/jbc.M116.714485